
Lilly Increases Access to Clinical Trials Data
Eli Lilly and Company has announced it will begin sharing its clinical trial data with scientific researchers through www.clinicalstudydatarequest.com.
Eli Lilly and Company has announced it will begin sharing its clinical trial data with scientific researchers through
The new portal,
The multi-sponsor portal will include Lilly-sponsored interventional clinical studies from approved medicines and indications in the U.S. and EU in the following categories:
- Phase 2, 3 or 4 studies used as part of a regulatory approval submitted to the U.S. Food and Drug Administration (FDA) on or after 1999;
- Phase 2, 3 or 4 global studies with a first patient visit after January 1, 2007; and
- Phase 2, 3 or 4 global or regional/local studies in indications approved in both the U.S. and EU with a first patient visit after January 1, 2014.
Lilly established
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.